Listar MED_Articles por autoría "b7cba4de-7261-4a9e-8bdb-27ee63f3bfd3"
Mostrando ítems 21-40 de 47
-
Fisiopatología renal y mecanismos farmacológicos de nefroprotección
Górriz, José Luis; Górriz-Zambrano, Carmen; Pallarés-Carratalá, Vicente Elsevier (2023-06)Son varios los factores de riesgo que pueden afectar la progresión de la enfermedad renal crónica (ERC). La hipertensión arterial, la proteinuria, la obesidad, la hipertensión intraglomerular, el tabaco y el control ... -
Gender differences in the diagnosis of dyslipidemia: ESCARVAL-GENERO
Soriano Maldonado, Cristina; Lopez-Pineda, Adriana; Orozco-Beltran, Domingo; QUESADA, JOSE ANTONIO; Alfonso Sanchez, Jose; Pallarés-Carratalá, Vicente; Navarro Pérez, Jorge; Gil-Guillen, Vicente F.; Martin-Moreno, Jose M.; Carratala-Munuera, Concepcion MDPI (2021)Evidence shows that objectives for detecting and controlling dyslipidemia are not being effectively met, and outcomes differ between men and women. This study aimed to assess gender-related differences in diagnostic inertia ... -
Gender Inequalities in Diagnostic Inertia around the Three Most Prevalent Cardiovascular Risk Studies: Protocol for a Population-Based Cohort Study
Carratala-Munuera, Concepcion; López Pineda, Adriana; Orozco-Beltran, Domingo; QUESADA, JOSE ANTONIO; Alfonso Sanchez, Jose; Pallarés-Carratalá, Vicente; Soriano Maldonado, Cristina; Navarro Pérez, Jorge; Gil-Guillén, Vicente F; Martin-Moreno, Jose M. MDPI (2021)Evidence shows that objectives for detecting and controlling cardiovascular risk factors are not being effectively met, and moreover, outcomes differ between men and women. This study will assess the gender-related differences ... -
Is the Physician’s Behavior in Dyslipidemia Diagnosis in Accordance with Guidelines? Cross-Sectional Escarval Study
Palazón-Bru, Antonio; Gil-Guillén, Vicente F; Orozco Beltrán, Domingo; Pallarés-Carratalá, Vicente; Valls Roca, Francisco; Sanchis-Domenech, Carlos; Martin-Moreno, Jose M.; Redón, Josep; Navarro Pérez, Jorge; Fernández Giménez, Antonio; Pérez Navarro, Ana M.; Trillo, José L.; Usó, Ruth; Ruiz, Elías Public Library of Science (2014)Background: Clinical inertia has been defined as mistakes by the physician in starting or intensifying treatment when indicated. Inertia, therefore, can affect other stages in the healthcare process, like diagnosis. The ... -
Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study
Orozco Beltrán, Domingo; Gil-Guillén, Vicente F; Redón, Josep; Martin-Moreno, Jose M.; Pallarés-Carratalá, Vicente; Navarro Pérez, Jorge; Valls Roca, Francisco; Sanchis-Domenech, Carlos; Fernández Giménez, Antonio; Pérez Navarro, Ana M.; Bertomeu-Martínez, Vicente; Cordero, Alberto; Pascual de la Torre, Manuel; Trillo, José L.; Carratala-Munuera, Concepcion; Pita Fernández, Salvador; Usó, Ruth; Durazo-Arvizu, Ramon; Cooper, Richard; Sanz, Ginés; Castellano, José M.; Ascaso, Juan F; Carmena, Rafael; Tellez-Plaza, Maria; ESCARVAL Study Group; Bertomeu-González, Vicente Public Library of Science (2017)Introduction The potential impact of targeting different components of an adverse lipid profile in populations with multiple cardiovascular risk factors is not completely clear. This study aims to assess the association ... -
Los desafíos del profesorado clínico en la educación médica
Palau, Patricia; Domínguez Mafé, Eloy; Llueca, Antoni; Nuñez, Julio; Bertomeu-González, Vicente; Sanchez-Andres, Juan V.; Pallarés-Carratalá, Vicente Elsevier (2017-11-04)Background: There is a unique particularity of clinical teaching in medical education that isbeyond knowledge, skills or teaching methods of each clinician: this is clinical teaching context.This study aimed to analyze the ... -
Luces y sombras de la Guía Europea ESC-2021 de Prevención de la Enfermedad Cardiovascular en la Práctica Clínica
Martín Rioboó, Enrique; Brotons, Carlos; Ruiz-Garcia, Antonio; Villafañe Sanz, Fatima Victoria; Frias Vargas, Manuel; Moyá Amengual, Ana; DIVISÓN GARROTE, JUAN ANTONIO; seoane vicente, maria; Banegas Banegas, José Ramón; Pallarés-Carratalá, Vicente Ministerio de Sanidad y Consumo (2023)General practitioners see in their consultation a a significant number of patients at high vascular risk (VR). The European Guidelines for Cardiovascular Disease Prevention (2021) recommend a new risk classification and ... -
Magnitude of pharmacological nonadherence in hypertensive patients taking antihypertensive medication from a community pharmacy in Spain
Perseguer Torregrosa, Zeneida; Orozco Beltrán, Domingo; Gil-Guillén, Vicente F; Pita Fernández, Salvador; Carratalá Munuera, Concepción; Pallarés-Carratalá, Vicente; López Pineda, Adriana Academy of Managed Care Pharmacy (2014-12)BACKGROUND: The most common factor associated with poor control of hypertension is treatment nonadherence to antihypertensive drug therapy. OBJECTIVE: To measure drug nonadherence and associated factors in pharmacologically ... -
Manejo clínico-práctico de los inhibidores del cotransportador sodio-glucosa tipo 2 en pacientes con enfermedad renal crónica
Castillo Moraga, María José; Turégano-Yedro, Miguel; Pallarés-Carratalá, Vicente Elsevier (2023-06)El descubrimiento del papel nefroprotector de los fármacos inhibidores del cotransportador sodio-glucosa tipo 2 (ISGLT2) en las personas con diabetes mellitus tipo 2 (DM 2) tras los resultados obtenidos en los respectivos ... -
Mortality and cardiovascular disease burden of uncontrolled diabetes in a registry-based cohort: the ESCARVAL-risk study
Navarro Pérez, Jorge; Orozco Beltrán, Domingo; Gil-Guillén, Vicente F; Pallarés-Carratalá, Vicente; Valls Roca, Francisco; Fernández Giménez, Antonio; Pérez Navarro, Ana M.; Sanchis-Domenech, Carlos; Dominguez-Lucas, Alejandro; Martin-Moreno, Jose M.; Redón, Josep; Tellez-Plaza, Maria; ESCARVAL Study Group, / BMC (2018-09-04)Background: Despite the epidemiological evidence about the relationship between diabetes, mortality and cardiovascular disease, information about the population impact of uncontrolled diabetes is scarce. We aimed to ... -
Multidisciplinary management of cardiovascular disease in women: Delphi consensus
Gámez, José Mª; Pedreira Pérez, Mila; Fernández Olmo, María Rosa; Fasero, Maria; Inaraja, Veronica; Pallarés-Carratalá, Vicente Frontiers (2024)Background: Current clinical guidelines on cardiovascular disease (CVD) do not specifically address the female population. The aim of this consensus is to know the opinion of a group of experts on the management of CVD ... -
Non-compliance and therapeutic inertia: two unanswered questions in clinical practice
Pallarés-Carratalá, Vicente; Pascual Pérez, R. Informa Healthcare (2014) -
Optimización del control telemático de la presión arterial en atención primaria en España (Iniciativa Óptima): resultados de un estudio Delphi
Sánchez Peinador, Carmen; Torras Borrell, Joan; Castillo Moraga, María José; Egocheaga, Mª Isabel; Rodríguez Villalón, Xiana; Turégano Yedro, Miguel; Gamarra Ortiz, Javier; Domínguez Sardina, Manuel; Pallarés-Carratalá, Vicente Elsevier (2022)Objetivo Representantes de los grupos de trabajo de hipertensión o enfermedad cardiovascular de las Sociedades Españolas de Médicos de Atención Primaria (MAP) [SEMERGEN], de Medicina Familiar y Comunitaria [semFYC] y de ... -
Overview of guidelines for the management of dyslipidemia: EU perspectives
Giner Galvañ, Vicente; Esteban Giner, María José; Pallarés-Carratalá, Vicente Dove Press (2016-09)Modern medicine is characterized by a continuous genesis of evidence making it very difficult to translate the latest findings into a better clinical practice. Clinical practice guidelines (CPG) emerge to provide ... -
La pandemia por la COVID-19: una oportunidad para cambiar la forma de atender a nuestros pacientes
Pallarés-Carratalá, Vicente; Górriz-Zambrano, Carmen; Llisterri Caro, José Luis; Górriz, José Luis Elsevier (2020) -
Posicionamiento SEMERGEN en el abordaje de la insuficiencia cardíaca crónica en atención primaria
Castillo Moraga, María José; Turégano-Yedro, Miguel; Pallarés-Carratalá, Vicente; Seoane-Vicente, M.C.; Serrano-Cumplido, A.; Ruiz-García, A.; Martin-Rioobó, E.; Escobar-Cervantes, C.; Polo-García, J.; Barrios, V. Elsevier (2022)La insuficiencia cardíaca (IC) es un problema de salud pública que genera una gran carga asistencial tanto hospitalaria como en atención primaria (AP). La publicación de numerosos estudios sobre IC durante los últimos ... -
Post-event follow-up costs in patients with atherosclerotic cardiovascular disease in Spain
Martínez López, Icíar; GOMEZ CEREZO, JORGE FRANCISCO; Gámez, José Mª; Egocheaga Cabello, Isabel; Castellanos, María del Mar; Campuzano Ruiz, Raquel; barrios, vivencio; Pallarés-Carratalá, Vicente; Rodríguez, José Manuel; Morant Talamante, Nuria; Parrondo, Javier; Mostaza, José María Frontiers (2024)Introduction: Atherosclerotic cardiovascular disease (ASCVD) is one of the main causes of morbidity and mortality in developed countries and entails high resources use and costs for health systems. The risk of suffering ... -
Predictive Models for Forecasting Public Health Scenarios: Practical Experiences Applied during the First Wave of the COVID-19 Pandemic
Martin-Moreno, Jose M.; Alegre Martínez, Antoni; Martin-Gorgojo, Victor; Alfonso Sanchez, Jose; Torres, Ferran; Pallarés-Carratalá, Vicente MDPI (2022-05-03)Background: Forecasting the behavior of epidemic outbreaks is vital in public health. This makes it possible to anticipate the planning and organization of the health system, as well as possible restrictive or preventive ... -
Prevalence of Hyperuricemia and Its Association with Cardiovascular Risk Factors and Subclinical Target Organ Damage
Antelo Pais, Paula; PRIETO-DIAZ, MIGUEL ANGEL; MICÓ PÉREZ, RAFAEL MANUEL; Pallarés-Carratalá, Vicente; Velilla-zancada, Sonsoles; Polo García, José Luis; barquilla garcía, alfonso; Ginel-Mendoza, Leovigildo; Segura Fragoso, Antonio; Vitelli-Storelli, Facundo; Martin, V.; Hermida-Ameijeiras, Alvaro; Cinza-Sanjurjo, Sergio MDPI (2022-12-21)The role of uric acid levels in the cardiovascular continuum is not clear. Our objective is to analyze the prevalence of hyperuricemia (HU) and its association with cardiovascular risk factors (CVRF), subclinical target ... -
Prevalence Rates of Arterial Hypertension According to the Threshold Criteria of 140/90 or 130/80 mmHg and Associated Cardiometabolic and Renal Factors: SIMETAP-HTN Study
Pallarés-Carratalá, Vicente; Ruiz-Garcia, Antonio; Serrano-Cumplido, Adalberto; Arranz-Martínez, Ezequiel; DIVISÓN GARROTE, JUAN ANTONIO; Moyá Amengual, Ana; Escobar, Carlos; barrios, vivencio MDPI (2023)Background and objectives: Arterial hypertension (HTN) is the leading preventable cause of atherosclerotic cardiovascular diseases (ASCVD) and death from all causes. This study aimed to determine the prevalence rates of ...